Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Cholinergic Drugs Market by Type (Powder, Tablet, Capsule), By Application (Hospital Pharmacy, Retail Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Cholinergic Drugs Market by Type (Powder, Tablet, Capsule), By Application (Hospital Pharmacy, Retail Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 279039 4200 Pharma & Healthcare 377 129 Pages 4.8 (35)
                                          

Market Overview:


The global cholinergic drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of neurological disorders, rising geriatric population, and growing demand for cholinergic drugs in hospitals and retail pharmacies. Based on type, the global cholinergic drugs market is segmented into powder, tablet, and capsule. The tablet segment is expected to account for the largest share of the global cholinergic drugs market in 2018. This segment is also projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to its high adoption rate among patients suffering from neurological disorders such as Alzheimer’s disease and dementia. Based on application, the global cholinergic drugs market is divided into hospital pharmacy and retail pharmacy segments.


Global Cholinergic Drugs Industry Outlook


Product Definition:


Cholinergic drugs are a type of medication that increases the amount of acetylcholine in the body. Acetylcholine is a neurotransmitter that helps to control muscle movement, heart rate, and other important functions. Cholinergic drugs are used to treat conditions such as Alzheimer's disease, myasthenia gravis, and urinary incontinence. They may also be used to improve memory function in people with age-related memory loss.


Powder:


Powder is a fine white crystalline powder, which is used as an intermediate in the production of acetylcholine. It can be extracted from lecithinized cell membranes and other sources. The extraction process involves solvent extraction, vacuum evaporation method and crystallization.


Tablet:


A tablet is a pharmaceutical preparation containing an amount of drug sufficient to fulfill the requirements for therapeutic action. Tablets are available in different forms such as film, oral, and effervescent. The size and shape of tablets vary according to their use i.e., single-dose or multi-dose tableting machines are available in the market based on patient’s needs.


The tablet is one of the oldest pharmaceutical packaging formats which has been used since 1000 B.


Application Insights:


The market is segmented by application into hospital pharmacy, retail pharmacy and others. The other applications include clinics, home care and medical tourism. Hospital pharmacies are expected to be the fastest-growing segment owing to the growing demand for cholinergic drugs in this setting. This is due to factors such as increasing geriatric population with Alzheimer¢â‚¬â„¢s disease or Parkinson¢â‚¬â„¢s disease; rising awareness about these disorders; and availability of advanced treatment facilities in hospitals resulting in increased usage of cholinergic drugs among patients suffering from these diseases at a global level.


Choline esters such as Chloride & Choline Ester (Chenodeg), Dopamine Agonist (Dopa).


Regional Analysis:


North America dominated the global market in 2017 owing to the presence of a large number of key players and high healthcare expenditure. Moreover, increasing incidence of Alzheimer’s disease (AD) is expected to boost cholinergic drug demand in this region. According to AD Research Center, Inc., approximately 5 million Americans have been diagnosed with AD; however, it is estimated that around 10% of adults age 65 years and older have symptoms suggestive of cognitive impairment due to AD. Thus, an increase in prevalence coupled with rising awareness about early diagnosis will fuel regional growth over the forecast period.


Asia Pacific market for global cholinergic drugs is anticipated to witness lucrative growth during the forecast period owing its rapidly developing economy along with growing geriatric population base and increasing prevalence of neurodegenerative disorders such as Parkinson's disease (PD).


Growth Factors:


  • Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for cholinergic drugs in the coming years.
  • Growing awareness about cholinergic drugs: There is growing awareness among people about the benefits of cholinergic drugs and this is likely to boost the demand for these drugs in the near future.
  • Rising prevalence of neurodegenerative diseases: The prevalence of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease is on the rise globally, which is expected to fuel demand for cholinergic drugs in the coming years.
  • Technological advancements: There has been significant progress in technology over recent years, which has led to development of new and better-quality cholinergic drugs products that are likely to boost market growth over forecast period. 5) Emerging markets offer potential growth opportunities: The Cholinergic Drugs market offers potential growth opportunities in emerging markets such as India, China, Brazil, etc., owing to rising disposable income levels and growing awareness about these products

Scope Of The Report

Report Attributes

Report Details

Report Title

Cholinergic Drugs Market Research Report

By Type

Powder, Tablet, Capsule

By Application

Hospital Pharmacy, Retail Pharmacy

By Companies

Allergan, Novartis AG, Eisai Co, H Lundbeck A/S, Daiichi Sankyo Company Limited, Ono Pharmaceutical Co Ltd, Johnson & Johnson

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

129

Number of Tables & Figures

91

Customization Available

Yes, the report can be customized as per your need.


Global Cholinergic Drugs Market Report Segments:

The global Cholinergic Drugs market is segmented on the basis of:

Types

Powder, Tablet, Capsule

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital Pharmacy, Retail Pharmacy

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Allergan
  2. Novartis AG
  3. Eisai Co
  4. H Lundbeck A/S
  5. Daiichi Sankyo Company Limited
  6. Ono Pharmaceutical Co Ltd
  7. Johnson & Johnson

Global Cholinergic Drugs Market Overview


Highlights of The Cholinergic Drugs Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Powder
    2. Tablet
    3. Capsule
  1. By Application:

    1. Hospital Pharmacy
    2. Retail Pharmacy
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cholinergic Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Cholinergic Drugs Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Cholinergic drugs are medications that work by increasing the levels of choline in the brain. This can improve memory and cognitive function.

Some of the major companies in the cholinergic drugs market are Allergan, Novartis AG, Eisai Co, H Lundbeck A/S, Daiichi Sankyo Company Limited, Ono Pharmaceutical Co Ltd, Johnson & Johnson.

The cholinergic drugs market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cholinergic Drugs Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Cholinergic Drugs Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Cholinergic Drugs Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Cholinergic Drugs Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Cholinergic Drugs Market Size & Forecast, 2018-2028       4.5.1 Cholinergic Drugs Market Size and Y-o-Y Growth       4.5.2 Cholinergic Drugs Market Absolute $ Opportunity

Chapter 5 Global Cholinergic Drugs Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Cholinergic Drugs Market Size Forecast by Type
      5.2.1 Powder
      5.2.2 Tablet
      5.2.3 Capsule
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Cholinergic Drugs Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Cholinergic Drugs Market Size Forecast by Applications
      6.2.1 Hospital Pharmacy
      6.2.2 Retail Pharmacy
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Cholinergic Drugs Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Cholinergic Drugs Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Cholinergic Drugs Analysis and Forecast
   9.1 Introduction
   9.2 North America Cholinergic Drugs Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Cholinergic Drugs Market Size Forecast by Type
      9.6.1 Powder
      9.6.2 Tablet
      9.6.3 Capsule
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Cholinergic Drugs Market Size Forecast by Applications
      9.10.1 Hospital Pharmacy
      9.10.2 Retail Pharmacy
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Cholinergic Drugs Analysis and Forecast
   10.1 Introduction
   10.2 Europe Cholinergic Drugs Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Cholinergic Drugs Market Size Forecast by Type
      10.6.1 Powder
      10.6.2 Tablet
      10.6.3 Capsule
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Cholinergic Drugs Market Size Forecast by Applications
      10.10.1 Hospital Pharmacy
      10.10.2 Retail Pharmacy
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Cholinergic Drugs Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Cholinergic Drugs Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Cholinergic Drugs Market Size Forecast by Type
      11.6.1 Powder
      11.6.2 Tablet
      11.6.3 Capsule
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Cholinergic Drugs Market Size Forecast by Applications
      11.10.1 Hospital Pharmacy
      11.10.2 Retail Pharmacy
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Cholinergic Drugs Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Cholinergic Drugs Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Cholinergic Drugs Market Size Forecast by Type
      12.6.1 Powder
      12.6.2 Tablet
      12.6.3 Capsule
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Cholinergic Drugs Market Size Forecast by Applications
      12.10.1 Hospital Pharmacy
      12.10.2 Retail Pharmacy
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Cholinergic Drugs Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Cholinergic Drugs Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Cholinergic Drugs Market Size Forecast by Type
      13.6.1 Powder
      13.6.2 Tablet
      13.6.3 Capsule
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Cholinergic Drugs Market Size Forecast by Applications
      13.10.1 Hospital Pharmacy
      13.10.2 Retail Pharmacy
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Cholinergic Drugs Market: Competitive Dashboard
   14.2 Global Cholinergic Drugs Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Allergan
      14.3.2 Novartis AG
      14.3.3 Eisai Co
      14.3.4 H Lundbeck A/S
      14.3.5 Daiichi Sankyo Company Limited
      14.3.6 Ono Pharmaceutical Co Ltd
      14.3.7 Johnson & Johnson

Our Trusted Clients

Contact Us